Capital Investment Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
15,443
+4,997
+48% +$403K 0.07% 270
2026
Q1
$905K Sell
10,446
-322
-3% -$30.8K 0.07% 275
2025
Q4
$1.03M Sell
10,768
-715
-6% -$69.5K 0.07% 253
2025
Q3
$1.09M Buy
11,483
+162
+1% +$14.9K 0.09% 233
2025
Q2
$987K Sell
11,321
-248
-2% -$21K 0.08% 227
2025
Q1
$1.04M Sell
11,569
-641
-5% -$57.4K 0.09% 207
2024
Q4
$975K Sell
12,210
-487
-4% -$42.2K 0.09% 192
2024
Q3
$1.14M Sell
12,697
-578
-4% -$48.6K 0.11% 182
2024
Q2
$1.04M Sell
13,275
-814
-6% -$66.7K 0.11% 187
2024
Q1
$1.23M Sell
14,089
-32
-0.2% -$2.73K 0.13% 168
2023
Q4
$1.16M Sell
14,121
-2,025
-13% -$154K 0.11% 169
2023
Q3
$1.27M Sell
16,146
-557
-3% -$46.6K 0.12% 152
2023
Q2
$1.47M Buy
16,703
+944
+6% +$81.3K 0.15% 126
2023
Q1
$1.27M Sell
15,759
-216
-1% -$17.6K 0.15% 137
2022
Q4
$1.24M Buy
15,975
+232
+1% +$18.8K 0.15% 132
2022
Q3
$1.27M Sell
15,743
-1,041
-6% -$93.6K 0.16% 117
2022
Q2
$1.51M Sell
16,784
-38
-0.2% -$3.85K 0.18% 111
2022
Q1
$1.87M Buy
16,822
+598
+4% +$63.2K 0.2% 96
2021
Q4
$1.68M Buy
16,224
+4,475
+38% +$518K 0.2% 111
2021
Q3
$1.47M Sell
11,749
-1,235
-10% -$160K 0.19% 113
2021
Q2
$1.61M Sell
12,984
-970
-7% -$122K 0.2% 101
2021
Q1
$1.65M Sell
13,954
-924
-6% -$108K 0.23% 94
2020
Q4
$1.74M Buy
14,878
+2,354
+19% +$259K 0.26% 87
2020
Q3
$1.3M Sell
12,524
-1,314
-9% -$132K 0.24% 92
2020
Q2
$1.27M Sell
13,838
-248
-2% -$23.8K 0.26% 87
2020
Q1
$1.27M Buy
14,086
+5,056
+56% +$538K 0.31% 70
2019
Q4
$1.02M Buy
9,030
+1,443
+19% +$158K 0.27% 80
2019
Q3
$824K Buy
7,587
+41
+0.5% +$4.28K 0.23% 88
2019
Q2
$764K Buy
7,546
+5,387
+250% +$492K 0.23% 90
2019
Q1
$197K Sell
2,159
-626
-22% -$56K 0.07% 225
2018
Q4
$261K Sell
2,785
-67
-2% -$6.26K 0.11% 170
2018
Q3
$281K Buy
+2,852
New +$264K 0.13% 169

Other funds holding MDT

Capital Investment Advisory Services's MDT Position: Q2 2026 in Review

Capital Investment Advisory Services increased its Medtronic (MDT) stake by 48% in Q2 2026, buying an estimated $403K and bringing the position to 15,443 shares worth $1.21M. The position accounts for 0.07% of the portfolio, ranked #270.

Capital Investment Advisory Services first reported a position in MDT in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.87M in Q1 2022. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Capital Investment Advisory Services held 15,443 shares of Medtronic worth $1.21M as of Q2 2026.
  • Capital Investment Advisory Services bought 4,997 Medtronic shares in Q2 2026, an estimated $403K.
  • Medtronic made up 0.07% of Capital Investment Advisory Services's portfolio in Q2 2026, its #270 holding.
  • Capital Investment Advisory Services first reported a position in Medtronic in Q3 2018 and has held it in 32 quarters since.
  • Capital Investment Advisory Services's Medtronic position peaked at $1.87M in Q1 2022.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.